GALD.SW · SIX Swiss Exchange
GALDERMA GROUP N AG
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$45.46bnFinancials dated 31 December 2025Price dated 2 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- Unavailable
- Latest-quarter run-rate earnings
- Unavailable
- Latest fiscal-year earnings
- Unavailable
- Trailing revenue
- Unavailable
- Latest-quarter run-rate revenue
- Unavailable
- Latest fiscal-year revenue
- Unavailable
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- FSZ · First Trust Switzerland AlphaDEX Fund4.28% weight · Holdings dated 30 June 2026
- FPXE · First Trust IPOX Europe Equity Opportunities ETF4.20% weight · Holdings dated 30 June 2026
- OSEA · Harbor International Compounders ETF3.05% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- EWL · iShares MSCI Switzerland ETF2.20% weight · Holdings dated 21 August 2026
- FPXI · First Trust International Equity Opportunities ETF1.76% weight · Holdings dated 30 June 2026
- BMED · iShares Health Innovation Active ETF1.39% weight · Holdings dated 21 August 2026
- GDOC · Goldman Sachs Future Health Care Equity ETF1.10% weight · Holdings dated 31 May 2026
- PIEL · Pacer International Export Leaders ETF0.77% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- SHSSX · BlackRock Health Sciences Opportunities Portfolio Institutional Shares0.67% weight · Holdings dated 29 May 2026
- POGAX · Putnam Large Cap Growth Fund Class A0.63% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
Sources and limitations
Financial inputs are attributed to EU issuer annual report. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 31 December 2025. Informational research, not investment advice.